Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants
about
Consensus Conference on Clinical Management of pediatric Atopic DermatitisPimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In VitroAtopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology.Acute Pustular Dermatosis, Following Topical Treatment With Pimecrolimus, in a Child Affected With Atopic and Contact Hand DermatitisThe adaptive immune system in atopic dermatitis and implications on therapy.Treatment of allergic children - Where is the progress (for the practicing allergist)?Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies.Chronic Pruritus: Current and Emerging Treatment Options.Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial.Treating pediatric atopic dermatitis: current perspectives.ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients.Food allergy and atopic dermatitis: Prediction, progression, and prevention.Guidelines for the management of atopic dermatitis (eczema) for pharmacists.Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation.
P2860
Q28071974-A7007AD6-A0C6-4696-BBAF-C2F94C68CC85Q35839772-AAFC0549-EC2A-4377-84A6-CB5042C46BEEQ36048469-04120100-4F43-4793-8296-313A98357A09Q36652818-FDBB40B7-0895-463C-8FDA-AB9EB277369AQ38769936-235B2E18-8769-4A85-A4C5-A3CCC3993998Q38809512-50CE90C1-3282-4EF6-A1D1-C3D75F20F725Q38860798-9A0793BB-4F23-4EF3-8AAF-F032725CF0CEQ39156148-E55D55D4-CD48-4F04-8976-AF60DF86D64BQ39419931-66F22166-3905-4183-99AA-523A6927EB8BQ47586019-EAC11206-87C8-4330-9232-C87B1887D47AQ47699085-7AD2EB99-F897-44AD-9E41-A9BBDF199EA1Q47849230-1B653FBA-824E-43BB-968A-CE059D66A41FQ48340626-0D5922D8-1BBB-4DAF-9E20-FB0A02E59DC6Q50144719-AFFE2D08-5EFF-4B9B-A1EB-6BFDD879AC6AQ50756733-D2EF7702-3901-4431-ADF5-6BCF4408E2A2
P2860
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@ast
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@en
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@nl
type
label
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@ast
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@en
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@nl
prefLabel
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@ast
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@en
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@nl
P2093
P2860
P50
P356
P1476
Pimecrolimus in atopic dermati ...... e need to allow use in infants
@en
P2093
Adelaide A Hebert
Alain Taieb
Antonella Muraro
Antonio Torrelo
Arnold P Oranje
Carlo Gelmetti
Eckard Hamelmann
Elaine Siegfried
Georg Stingl
Harald Gollnick
P2860
P304
P356
10.1111/PAI.12331
P407
P5008
P577
2015-06-01T00:00:00Z